data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Xenetic Biosciences

(NASDAQ:XBIO)

Intraday

$3.75

-0.25[-6.25%]

15 minutes delayed

Perks Buy Compare Brokers

$3.75

-0.25[-6.25%]

Last update: 6:57PM Get Real Time Here

Overview News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest News for Xenetic Biosciences Stock (NASDAQ:XBIO)

Xenetic Biosciences Stock (NASDAQ: XBIO)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, March 25, 2024

CORRECTION: On Friday, Xenetic Biosciences Q4 GAAP EPS $(0.77) Beats $(0.87) Estimate, Sales $671.96K Miss $680.00K Estimate
Benzinga Newsdesk - Mar 25, 2024, 6:59AM

Wednesday, January 17, 2024

Xenetic Biosciences Enters Into Research Agreement With University Of Virginia For Advancement Of DNase-Based Oncology Platform
Benzinga Newsdesk - Jan 17, 2024, 9:05AM

Tuesday, December 05, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Dec 5, 2023, 12:31PM

Friday, November 10, 2023

Xenetic Biosciences: Q3 Earnings Insights
Benzinga Insights - Nov 10, 2023, 9:10AM
Xenetic Biosciences Q3 EPS $(0.69) Beats $(1.12) Estimate, Sales $611.17K Beat $460.00K Estimate
Benzinga Newsdesk - Nov 10, 2023, 8:44AM

Friday, August 11, 2023

Xenetic Biosciences Reports Q2 Net Loss $(1.1)M, Cash Balance of $10.7M
Benzinga Newsdesk - Aug 11, 2023, 8:13AM

Tuesday, June 20, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jun 20, 2023, 9:13AM

Tuesday, May 16, 2023

Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences
Vandana Singh - May 16, 2023, 2:55PM
HC Wainwright & Co. Downgrades Xenetic Biosciences to Neutral
Benzinga Newsdesk - May 16, 2023, 6:27AM

Monday, May 15, 2023

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin - May 15, 2023, 1:45PM

Friday, May 12, 2023

Xenetic Biosciences shares are trading lower after the company announced a 1-for-10 reverse stock split.
Benzinga Newsdesk - May 12, 2023, 2:37PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - May 12, 2023, 1:31PM
Xenetic Biosciences, Inc. Announces 1-For-10 Reverse Stock Split Of Common Stock
Happy Mohamed - May 12, 2023, 12:33PM

Thursday, April 13, 2023

Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh - Apr 13, 2023, 2:54PM
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh - Apr 13, 2023, 7:38AM

Wednesday, April 12, 2023

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh - Apr 12, 2023, 9:46AM

Tuesday, April 11, 2023

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh - Apr 11, 2023, 2:28PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Apr 11, 2023, 9:06AM
Xenetic Biosciences, Inc. Announces Research And Development Collaboration With The Scripps Research Institute To Advance DNase Platform
Happy Mohamed - Apr 11, 2023, 8:32AM

Thursday, March 16, 2023

US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh - Mar 16, 2023, 8:56AM

Thursday, March 02, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Mar 2, 2023, 8:06AM

Wednesday, March 01, 2023

FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh - Mar 1, 2023, 1:24PM

Monday, February 06, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Feb 6, 2023, 12:31PM

Tuesday, January 17, 2023

Xenetic Biosciences, Inc. Announces Notice Of Allowance For Canadian Patent Covering Use Of DNase Enzyme For Preventing Or Ameliorating Toxicity Associated With Chemotherapy
Benzinga Newsdesk - Jan 17, 2023, 8:06AM

Monday, December 19, 2022

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Dec 19, 2022, 4:31PM

Friday, December 16, 2022

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Dec 16, 2022, 12:39PM

Wednesday, November 30, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Nov 30, 2022, 8:09AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Nov 30, 2022, 8:09AM

Wednesday, November 16, 2022

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Nov 16, 2022, 2:02PM

Thursday, November 10, 2022

Xenetic Biosciences Says Ended Q3 2022 With $13.8M Of Cash Expected To Fund Operations, Drive Expanded Pipeline
Benzinga Newsdesk - Nov 10, 2022, 7:09AM

Friday, October 28, 2022

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Oct 28, 2022, 12:12PM

Wednesday, October 12, 2022

Xenetic Biosciences Says Co. Entered Into Subscription Agreement With CLS Therapeutics, Pursuant To Which Co. Agreed To Issue 850K Shares To CLS
Michael Horton - Oct 12, 2022, 5:05PM

Tuesday, October 11, 2022

Xenetic Biosciences, Inc. Announces Signing Of Patent Assignment Related To Collaboration With VolitionRx Limited And CLS Therapeutics
Bill Haddad - Oct 11, 2022, 8:08AM

Friday, August 12, 2022

Xenetic Biosciences Cash Position $14.9M
Bill Haddad - Aug 12, 2022, 8:08AM

Tuesday, August 02, 2022

Xenetic Biosciences, VolitionRx Limited Collaborate To Develop NETs-Targeted Adoptive Cell Therapies For The Treatment Of Cancer
Benzinga Newsdesk - Aug 2, 2022, 8:06AM

Wednesday, May 04, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - May 4, 2022, 5:43PM

Monday, May 02, 2022

HC Wainwright & Co. Maintains Buy on Xenetic Biosciences, Lowers Price Target to $4
Benzinga Newsdesk - May 2, 2022, 6:08AM

Friday, April 29, 2022

74 Biggest Movers From Yesterday
Lisa Levin - Apr 29, 2022, 5:19AM

Thursday, April 28, 2022

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Apr 28, 2022, 3:31PM
48 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Apr 28, 2022, 12:05PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Apr 28, 2022, 8:16AM
28 Stocks Moving in Thursday's Pre-Market Session
Lisa Levin - Apr 28, 2022, 6:30AM

Wednesday, April 27, 2022

Xenetic Biosciences Enters Exclusive License And Sublicense Agreements With CLS Therapeutics; Xenetic To Make Upfront Payment Of $500K In Cash And Issue 875K Shares Of Common Stock As Well As Up To $13M In Future Milestones
Bill Haddad - Apr 27, 2022, 6:45AM

Tuesday, March 08, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Mar 8, 2022, 4:47PM

Wednesday, February 23, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Feb 23, 2022, 4:41PM

Tuesday, January 18, 2022

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Jan 18, 2022, 10:59AM

Tuesday, January 11, 2022

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jan 11, 2022, 8:08AM

Wednesday, December 08, 2021

'We are expanding the potential of CAR T cell therapy through the development of our XCART technology platform...' -Tweet From Xenetic Biosciences
Benzinga Newsdesk - Dec 8, 2021, 11:24AM

Monday, November 22, 2021

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Nov 22, 2021, 9:06AM

Friday, November 12, 2021

Xenetic Biosciences Q3 2021 Net Loss $(1.4)M
Benzinga Newsdesk - Nov 12, 2021, 8:04AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved